welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Nutritional Agents With Anti-inflammatory Properties in Chemoprevention of Colorectal Neoplasia
source: Recent results in cancer research
year: 2013
authors: Hull M A
summary/abstract:The strong link between inflammation and colorectal carcinogenesis provides the rationale for using anti-inflammatory agents for chemoprevention of colorectal cancer (CRC). Several naturally occurring substances with anti-inflammatory properties, used in a purified ‘nutraceutical’ form, including omega-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and polyphenols such as curcumin and resveratrol, have been demonstrated to have anti-CRC activity in preclinical models. As expected, these agents have an excellent safety and tolerability profile in Phase II clinical trials. Phase III randomized clinical trials of these naturally occurring substances are now beginning to be reported. The omega-3 polyunsaturated fatty acid EPA, in the free fatty acid (FFA) form, has been demonstrated to reduce adenomatous polyp number and size in patients with familial adenomatous polyposis (FAP), a finding which has prompted evaluation of this formulation of EPA for prevention of ‘sporadic’ colorectal neoplasia. Anti-inflammatory ‘nutraceuticals’ require further clinical evaluation in polyp prevention trials as they exhibit many of the characteristics of the ideal cancer chemoprevention agent, including safety, tolerability and patient acceptability.
organization: St James's University HospitalDOI: 10.1007/978-3-642-30331-9_8
read more
expertly curated content related to this topic
-
Familial Adenomatous Polyposis by Douglas Riegert Johnsonhttp://www.slideshare.net/douglasriegert...
-
Clinical Management of Adenomatous Polyposis in Patients with Hereditary Non-Polyposis Colorectal Cancer and Familia...OBJECTIVE : To investigate the validity ...
-
Cancer Prevention Pharmaceuticals announces last patient completes phase 3 trial protocol of CPP-1X/sul for familial...Cancer Prevention Pharmaceutic...
-
Sulindac Sulfone is Most Effective in Modulating Beta-Catenin-Mediated Transcription in Cells with Mutant APCSulindac sulfone (FGN-1, Aptosyn), a met...
-
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysisObjective The benefits of pancreatic ...
-
Colorectal Cancer GuidelinesThe American Society of Colon and Rectal...
-
St. Pattie’s Day Desmoid vlog Update!!!https://www.youtube.com/watch?v=w1Itd_Zx...